Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TYSABRI vs UMBRALISIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TYSABRI vs UMBRALISIB: Safety Overview

Metric TYSABRI UMBRALISIB
Total FAERS Reports 8,210 293
Deaths Reported 156 30
Death Rate 1.9% 10.2%
Hospitalizations 1,256 97
Average Patient Age 46.4 yrs 69.0 yrs
% Female Patients N/A 43.8%
FDA Approval Date N/A Feb 5, 2021
Marketing Status N/A Discontinued